Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Market Cap	2.71B +95.8%
Revenue (ttm)	516.17M +5.5%
Net Income	6.52M +27.6%
EPS	0.32 +31.7%
Shares Out	20.80M
PE Ratio	415.10
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	145,745
Average Volume	32,635
Open	134.00
Previous Close	130.20
Day's Range	123.69 - 136.71
52-Week Range	54.99 - 147.00
Beta	0.57
RSI	58.27
Earnings Date	Feb 11, 2026

About NSE:LOTUSEYE

Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery t...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1989
• Employees: 348
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: LOTUSEYE

Financial Performance

In fiscal year 2025, NSE:LOTUSEYE's revenue was 495.63 million, an increase of 2.81% compared to the previous year's 482.10 million. Earnings were 7.39 million, a decrease of -74.63%.